In another study [42], nestin was analyzed immunohistochemically in 171 consecutive patients with NSCLC (131 with ADCs, 31 with SCCs, and 9 with others), and the effect of nestin expression on clinicopathological parameters and survival was evaluated. This evidence concerns the gene NES and non-small cell lung carcinoma.